11 – 20 of 34
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Direct neuronal reprogramming for disease modeling studies using patient-derived neurons : What have we learned?
(
- Contribution to journal › Scientific review
- 2016
-
Mark
Brain repair and reprogramming : the route to clinical translation
(
- Contribution to journal › Scientific review
-
Mark
Impaired thermoregulation and beneficial effects of thermoneutrality in the 3×Tg-AD model of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
GSK-3β-induced Tau pathology drives hippocampal neuronal cell death in Huntington's disease : involvement of astrocyte-neuron interactions
(
- Contribution to journal › Article
- 2015
-
Mark
Cystamine/cysteamine rescues the dopaminergic system and shows neurorestorative properties in an animal model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Cell-based therapies for Parkinson disease-past insights and future potential.
(
- Contribution to journal › Scientific review
-
Mark
The role of tau in the pathological process and clinical expression of Huntington's disease
(
- Contribution to journal › Article
-
Mark
Cerebrovascular and blood-brain barrier impairments in Huntington's disease : Potential implications for its pathophysiology
(
- Contribution to journal › Article
-
Mark
Dopamine and Huntington's disease
(
- Contribution to journal › Article
-
Mark
A novel combinational approach of microstimulation and bioluminescence imaging to study the mechanisms of action of cerebral electrical stimulation in mice
(
- Contribution to journal › Article